Baclesse Center News Today : Breaking News, Live Updates & Top Stories | Vimarsana

PEP-Therapy and Institut Curie initiate dosing in solid tumour trial

PEP-Therapy and Institut Curie initiate dosing in solid tumour trial
clinicaltrialsarena.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from clinicaltrialsarena.com Daily Mail and Mail on Sunday newspapers.

Antoine prestatGustave roussyInstitut curieBaclesse centerCell penetratingInterfering peptides

PEP-Therapy and Institut Curie announce first patients dosed in Phase I clinical trial of PEP-010 for the treatment of advanced solid tumors

/PRNewswire/ PEP-Therapy, a clinical-stage biotechnology company developing cell penetrating peptides as targeted therapies in oncology, and Institut Curie,.

Czech republicFrance generalMarie curieBernard majoieSylvie berrebiLaboratoires fournierChristophe le tourneauGustave roussyAntoine prestatInstitut curieSeed fundHead of the department drug developmentSorbonne universityFournier majoie foundation for innovationBaclesse centerCell penetrating